Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01249534

Enrollment

200

Registered

2010-11-30

Start date

2010-12-31

Completion date

2010-12-31

Last updated

2010-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Given Indication for Gastroesophageal Cancer Surgery

Brief summary

Although widely used, there is a lack of evidence concerning diagnostic value of C-reactive protein (CRP) in the postoperative course. The aim of this study was to evaluate the diagnostic accuracy of CRP for postoperative inflammatory complications after gastroesophageal cancer.

Interventions

OTHERgastroesophageal cancer surgery

gastroesophageal cancer surgery

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* all patients with gastroesophageal cancer surgery

Exclusion criteria

* lack of measurement of C-reactive protein

Design outcomes

Primary

Measure	Time frame
postoperative Inflammatory complications	30 days postoperatively

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026